Patent · US Active

αvβ6 peptide ligands and their uses

US8927501B2 · kind B2 · utility

5Cited by

1References

11Claims

0Family size

Assignee

Cancer Research Technology Limited · GB

Inventors

Mark J. Howard · Ashford, GB
Danielle Dicara · South San Francisco, US
John Marshall · London, GB

Key dates

Filing date	Jan 17, 2013
Grant date	Jan 6, 2015
Priority date	—
Expiry date	Jan 17, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

AVβ6 peptide ligands, functional variants thereof and their nucleic acids encoding them are disclosed with their uses in the treatment and imaging of AVβ6 mediated diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.